Hannan R - Search Results

1

Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.

Jacobs CD, Chun SG, Yan J, Xie XJ, Pistenmaa DA, Hannan R, Lotan Y, Roehrborn CG, Choe KS, Kim DW. Jacobs CD, et al. Among authors: hannan r. Cancer Biol Ther. 2014 Jun 1;15(6):699-706. doi: 10.4161/cbt.28554. Epub 2014 Mar 21. Cancer Biol Ther. 2014. PMID: 24658086 Free PMC article.

2

Prostate-specific antigen decline during salvage radiation therapy following prostatectomy is associated with reduced biochemical failure.

Kabarriti R, Ohri N, Hannan R, Tishbi N, Baliga S, McGovern KP, Mourad WF, Ghavamian R, Kalnicki S, Guha C, Garg MK. Kabarriti R, et al. Among authors: hannan r. Pract Radiat Oncol. 2014 Nov-Dec;4(6):409-14. doi: 10.1016/j.prro.2014.01.002. Epub 2014 Feb 22. Pract Radiat Oncol. 2014. PMID: 25407863

3

Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus.

Hannan R, Margulis V, Chun SG, Cannon N, Kim DW, Abdulrahman RE, Sagalowsky A, Pedrosa I, Choy H, Brugarolas J, Timmerman RD. Hannan R, et al. Cancer Biol Ther. 2015;16(5):657-61. doi: 10.1080/15384047.2015.1026506. Cancer Biol Ther. 2015. PMID: 25800036 Free PMC article.

4

Pretreatment biopsy analysis of DAB2IP identifies subpopulation of high-risk prostate cancer patients with worse survival following radiation therapy.

Jacobs C, Tumati V, Kapur P, Yan J, Xie XJ, Hannan R, Hsieh JT, Kim DW, Saha D. Jacobs C, et al. Among authors: hannan r. Cancer Med. 2015 Dec;4(12):1844-52. doi: 10.1002/cam4.554. Epub 2015 Oct 16. Cancer Med. 2015. PMID: 26471467 Free PMC article.

5

Stereotactic body radiation therapy for low and intermediate risk prostate cancer-Results from a multi-institutional clinical trial.

Hannan R, Tumati V, Xie XJ, Cho LC, Kavanagh BD, Brindle J, Raben D, Nanda A, Cooley S, Kim DWN, Pistenmaa D, Lotan Y, Timmerman R. Hannan R, et al. Eur J Cancer. 2016 May;59:142-151. doi: 10.1016/j.ejca.2016.02.014. Epub 2016 Mar 29. Eur J Cancer. 2016. PMID: 27035363 Clinical Trial.

6

Anatomical patterns of recurrence following biochemical relapse after post-prostatectomy salvage radiation therapy: a multi-institutional study.

Jackson WC, Desai NB, Abugharib AE, Tumati V, Dess RT, Lee JY, Zhao SG, Soliman M, Folkert M, Laine A, Hannan R, Zumsteg ZS, Sandler H, Hamstra DA, Montgomery JS, Miller DC, Kozminski MA, Hollenbeck BK, Hearn JW, Palapattu G, Tomlins SA, Mehra R, Morgan TM, Feng FY, Spratt DE. Jackson WC, et al. Among authors: hannan r. BJU Int. 2017 Sep;120(3):351-357. doi: 10.1111/bju.13792. Epub 2017 Feb 26. BJU Int. 2017. PMID: 28139024 Free article.

7

Natural history of 'second' biochemical failure after salvage radiation therapy for prostate cancer: a multi-institution study.

Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB. Tumati V, et al. Among authors: hannan r. BJU Int. 2018 Mar;121(3):365-372. doi: 10.1111/bju.13926. Epub 2017 Jul 5. BJU Int. 2018. PMID: 28581200 Free article.

8

Safety and Efficacy of Stereotactic Ablative Radiation Therapy for Renal Cell Carcinoma Extracranial Metastases.

Wang CJ, Christie A, Lin MH, Jung M, Weix D, Huelsmann L, Kuhn K, Meyer J, Desai N, Kim DWN, Pedrosa I, Margulis V, Cadeddu J, Sagalowsky A, Gahan J, Laine A, Xie XJ, Choy H, Brugarolas J, Timmerman R, Hannan R. Wang CJ, et al. Among authors: hannan r. Int J Radiat Oncol Biol Phys. 2017 May 1;98(1):91-100. doi: 10.1016/j.ijrobp.2017.01.032. Int J Radiat Oncol Biol Phys. 2017. PMID: 28587057 Free PMC article.

9

Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.

Jones RT, Hassan Rezaeian N, Desai NB, Lotan Y, Jia X, Hannan R, Kim DWN, Hornberger B, Dubas J, Laine AM, Zelefsky MJ, Timmerman RD, Folkert MR. Jones RT, et al. Among authors: hannan r. Med Dosim. 2017 Winter;42(4):341-347. doi: 10.1016/j.meddos.2017.07.002. Epub 2017 Jul 31. Med Dosim. 2017. PMID: 28774760

10

Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study.

Woldu SL, Matulay JT, Clinton TN, Singla N, Freifeld Y, Sanli O, Krabbe LM, Hutchinson RC, Lotan Y, Hammers H, Hannan R, Brugarolas J, Bagrodia A, Margulis V. Woldu SL, et al. Among authors: hannan r. Clin Genitourin Cancer. 2018 Dec;16(6):e1221-e1235. doi: 10.1016/j.clgc.2018.08.001. Epub 2018 Aug 25. Clin Genitourin Cancer. 2018. PMID: 30217763

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters